CA SB 524 Comment Letter (2021)
PCMA delivers a comment letter to the chair of the Assembly committee on Business and Professions addressing steering and mail order proposed provisions.
OK Coalition Comment Letter to BoP (2023)
Coalition letter in opposition to a Board of Pharmacy proposed rule that would require temperature controlled packaging for all drug delivery, regardless of specific temperature
MA Bundle of Bills Testimony (2021)
PCMA submits testimny to the Joint Committee on Financial Services regarding a bucket list of bills addressing a wide range of PBM regulations.
CA SB 524 Talking Points
Talking points addressing SB 524, a bill aimed at prohibiting PBM steering practices in California.
CA SB 524 Comment Letter
PCMA delivers a comment letter to the sponsor of SB 602, a bill that aims to prohibit PBMs ability to steer patients to lower cost,
CA SB 524 Comment Letter
PCMA provides comment letter to the CA Senate Health Committee opposing SB 524, an anti-steering bill. If enacted, the bill would prohibit PBMs from offering
PBMS are Taking Action to Promote Patient Access to Prescription Drugs During COVID-19 Pandemic
PCMA developed overiew addressing the actions PBMs are taking to address access and affordability of prescription drugs during the COVID-19 pandemic.
AL SB 236 Talking Points (2020)
These talking points address how Alabama Senate Bill 236 will impact private contracts and restrict the tools pharmacy benefit managers use to reduce prescription drug
PCMA Comment Letter OR HB 485 (2019)
This letter was submitted by PCMA regarding OR HB485 dealing with mail order pharmacies and clarification on the pharmacy appeal process.